Numidargistat

DB15286InvestigationalSmall molecule

CB-1158 is under investigation in clinical trial NCT03910530 (A Study of INCMGA00012, INCB001158, and the Combination in Japanese Participants With Advanced Solid Tumors).

Chemical structure of Numidargistat
Mechanism
Curator reviewed
Formula / weight
C11H22BN3O5 · 287.12 g/mol (avg)
Also known as
INCB001158
Code names
CB-1158

Resolves to

Compound
UNIIIFD73D535ACAS2095732-06-0
Structure
InChIKeyZZJLMZYUGLJBSO-LAEOZQHASA-NSMILESC[C@H](N)C(=O)N1C[C@H](CCCB(O)O)[C@@](N)(C1)C(O)=O
Targets
P05089ARG1

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
5Clinical trialsPhase, status and sponsor resolved per trial
Sign in
6+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Numidargistat, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In